Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Surefire Precision Infusion System Registry
- Status
- TERMINATED
- Phase
- N/A
Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail
- Status
- COMPLETED
- Phase
- PHASE4
Therasphere for Unresectable Primary or Secondary Liver Neoplasia
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse
- Status
- COMPLETED
- Phase
- PHASE1
DAA in the Risk of Recurrence After Curative Treatment of HCC
- Status
- WITHDRAWN
- Phase
- PHASE4
Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications
- Status
- UNKNOWN
- Phase
- NA
Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation
- Status
- SUSPENDED
- Phase
- NA
Clinical Significance of Hepatic and Circulating microRNAs miR-221 and miR-222 in Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- N/A
Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Liver and Biliary Tumor Tissue Registry
- Status
- TERMINATED
- Phase
- N/A
Randomized Phase II Trial of Chemoembolization and Sorafenib
- Status
- WITHDRAWN
- Phase
- PHASE2
Extracellular RNA Markers of Liver Disease and Cancer
- Status
- TERMINATED
- Phase
- N/A
Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)
- Status
- COMPLETED
- Phase
- PHASE1
FDGal PET/CT to Detect Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- N/A
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Dendritic Killer Cell-based Immunotherapy for Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1